Congress Program

Last update on September 28, 2021

November 25, 2021

 

Room A Day1- November 25, 2021 (Thursday)

Time

Program

Speaker/Country/Region

9.00-10.00 (Symposium 1) What's new in 2020 WHO classification of female genital tumors
Chair:  Ikuo Konishi (JPN)            Co-chair: Surapan Khunamornphong (THA)

9.00-9.15

Cervical cancer

Takako Kiyokawa (JPN)

9.15-9.30

Ovarian cancer

Kyu-Rae Kim (KOR)

9.30-9.45

Uterine cancer

Annie (Nga-Yin) Cheung (HKG)

9.45-10.00

Discussion

 

10.00-10.10   Break

10.10-10.40 Opening Ceremony & Awarding (Room A + B)
Moderators: Arb-aroon Lertkhachonsuk (THA), Kittipat Charoenkwan (THA)

10.10 -10.30

Opening remarks

Daisuke Aoki, ASGO President
Minister/Representative from Ministry of Public Health (THA)
Panon Kasemsarn, Chairman of LOC

10.30 – 10.40

 Awarding ceremony (Lifetime Achievement Awards) Jonathan Ledermann & Zeyi Cao

ASGO committee

10.40-11.10 Presidential lecture (Room A + B)
Chair: Ikuo Konishi (JPN)  Co-chair : Hee-Sug Ryu (KOR)
Lecture title: TBA  
Daisuke Aoki, The President of ASGO

11.10-12.00 (Special Session 2) WHO session: World mission on elimination of cervical cancer (Room A + B)
                              Chair: Sarikapan Wilailak (THA)         Co-chair : Young-Tae Kim (KOR)

11.10-11.30

WHO strategies to eliminate cervical cancer

Nathalie Broutet (WHO)

11.30-11.40

Cervical cancer in Asian region

Kazunori Ochiai (JPN)

11.40-11.50

Elimination of cervical cancer in Thailand

Karun Kengsakul (THA)

11.50-12.00

Q & A

 

12.00-13.00 Sponsored Symposium 1 (Roche Diagnostics (Thailand) Ltd.): Nationwide HPV DNA Primary Screening: Implementing more effective strategy


Speaker: Wichai Termrungruanglert (THA), Panon Kasemsarn (THA)

13.00-14.00  Best Oral Presentations
Chair:  Seung-Cheol Kim (KOR)                    Co-chair:  Kittipat Charoenkwan (THA)

13.00-13.10

A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01): First efficacy results of a 2-stage Simon’s design

Jung-Yun Lee (KOR)

13.10-13.20

Diagnosis value of circulating tumor DNA for ovarian cancer based on high-throughput sequencing technology

Yuming Shao (CHN)

13.20-13.30

Phase 3 study (Study 309/KEYNOTE-775) of lenvatinib plus pembrolizumab vs treatment of physician’s choice in advanced endometrial cancer: Japanese subset

Mayu Yunokawa (JPN)

13.30-13.40

Newly developed adoptive cell therapy with autologous tumor-infiltrating lymphocytes in cervical cancer

Iwata Takashi (JPN)

13.40-13.50 Effectiveness of adapted enhanced recovery after surgery protocol in open gynecologic oncology surgery: A randomized controlled trial Phasawee Chiewhatpong (THA)

13.50-14.00

Comments & Discussion

 

14.00-14.30 Break

14.30-15.30 (Plenary Session 1) Current situation of MIS in gynecologic cancer (Room A + B)
Chair:  Kung-Liahng Wang (TWN)                  Co-chair: Perapong Inthasorn THA)

14.30-14.45

Current situation of MIS in endometrial cancer

Masaaki Andou (JPN)

14.45-15.00

Laparoscopic surgery in cervical cancer

Chyi-Long Lee (TWN)

15.00-15.15

Robotic surgery in cervical cancer management

Joseph Ng (SIN)

15.15-15.30

Discussion

 

15.30-16.30 (Special Session 3) International research collaboration through APGOT
Chair: Keiichi Fujiwara (JPN)            Co-chair: David SP Tan (SIN)

15.30-15.45

ANZGOG activities

Philip Beale (AUS)

15.45-16.00

Making a success of IITs: The Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group and Investigator Initiated Trials

Jung-Yun Lee (KOR)

16.00-16.15

ENGOT achievement and perspective

Mansoor Mirza (DEN)

16.15-16.30

Discussion

 

16.30-17.30 (Plenary Session 2) Optimal management of recurrent ovarian cancer (Room A)
Chair:  Aikou Okamoto (JPN)                        Co-chair: David SP Tan (SIN)

16.30-16.45

Role & optimization of 2nd cytoreduction

Andreas du Bois (GER)

16.45-17.00

PARPi maintenance

Jonathan Ledermann (GBR)

17.00-17.15

The other assets targeting DNA damage repair

Sook-Hee Hong (KOR)

17.15-17.30

Discussion

 

18.00-20.00: Welcome Reception *

Room B Day1- November 25, 2021 (Thursday)

Time

Program

Speaker/Country/Region

9.00-10.00 (Special Session 1): Asian practice guidelines for gynecologic cancer
Chair:   Soon-Beom Kang (KOR)                 Co-chair: Xing Xie (CHN)   

9.00-9.15

Do ASCCP guidelines on management of abnormal cervical screenings affect Asian practice?

Yao-Ching Hung (TWN)

9.15-9.30

Guidelines for adjuvant treatment of endometrial cancer

Amita Maheshwari (IND)

9.30-9.45

Guideline and controversial issues in laparoscopic surgery for cervical cancer

Yang Xiang (CHN)

9.45-10.00

Guidelines for management of advanced ovarian cancer

Tsukasa Baba (JPN)

12.00-13.00 Sponsored Symposium 2(Hologic, Inc. + Winnergy Medical PCL.): A comparison of DNA and mRNA HPV testing in primary screening and the new WHO guidelines
Speaker: Jack Cuzick (GBR)

15.30-16.30 (Symposium 2) Roles and cost-utility of universal genetic testing in Asia
Chair: Suresh Kumarasamy (MAS)                 Co-chair: Arb-aroon Lertkhachonsuk (THA)

15.30-15.45

Mainstreaming genetic counselling for ovarian cancer patients

Suresh Kumarasamy (MAS)

15.45-16.00

The “BRCAness” syndrome in epithelial ovarian cancer 

David SP Tan (SIN)

16.00-16.15

Utility of genetic testing in gynecologic cancer: Korean strategy

Youn-Jin Choi (KOR)

16.15-16.30

                                         Discussion

 

16.30-17.30 (Tumor Board 1) Surgical management for early & advanced endometrial cancer
                              Chair:   Mikio Mikami (JPN)           Co-chair: Zhiqing Liang(CHN)

16.30-16.40

Case presentation 1:  Early endometrial cancer

Lukkana Promwattanaphan (THA)

16.40-16.55

Comments on case management

Hee-Seung Kim (KOR)

16.55-17.00

Discussion

Chair/ co-chair/ participants

17.00-17.10

Case presentation 2: Advanced endometrial cancer

Kamaitorn Tientong (THA)

17.10-17.25

Comments on case management

Rainer Kimmig (GER)

17.25-17.30

Discussion

Chair/ co-chair/ participants

18.00-20.00: Welcome Reception *

 

Room C Day1- November 25, 2021 (Thursday)

Time

Program

Speaker/Country/Region

13.00-14.30 (Special Session) Shingo Fujii Medical Academy:  Helpful ideas, devices and precise anatomies for hysterectomy
Chair: Shingo Fujii (JPN)                            Co-chair: Joo-Hyun Nam (KOR)

13.00-13.30

Helpful ideas and devices for safe and reproducible laparoscopic hysterectomy

Yasuhiko Shiki(JPN)

13.30-14.00

Precise surgical anatomy of the paracervical area

Kentaro Sekiyama(JPN)

14.00-14.30

Precise anatomy of the inferior hypogastric plexus in the female pelvis

Kenro Chikazawa(JPN)

14.30-15.00

Discussion

 

 

 


November 26, 2021

 

Room A Day2- November 26, 2021 (Friday)

Time

Program

Speaker/Country/Region

8.30-9.30 (Symposium 4) Onco-fertility & ovarian preservation in gynecologic cancer
Chair:  Rongyu Zang (CHN)             Co-chair: Suwanit Therasakvichya (THA)

8.30-8.45

Fertility preservation in women with gynecologic cancer

Nao Suzuki (JPN)

8.45-9.00

Ovarian preservation in women with gynecologic cancer

Kun Song (CHN)

9.00-9.15

Uterine preservation in women with gynecologic cancer

Jeong-Yeol Park (KOR)

9.15-9.30

Discussion

 

9.30-10.30 (Education Session 1) GTN review & update
Chair:  Hextan YS Ngan (HKG)                 Co-chair: Yang Xiang (CHN)

9.30-9.50

Hydatidiform mole, Diagnosis & Classification of GTN

Ruangsak Lertkhachonsuk (THA)

9.50-10.10

Management of low-risk GTN

Karen KL Chan (HKG)

  10.10-10.30

Management of high- and ultra high-risk GTN

Min-Chul Choi (KOR)

10.30-11.00  Break

11.00-12.00 (Plenary Session 3) ASGO-AOGIN joint session: Combined strategies of HPV vaccination & screening
towards 4C's in Asia  (Room A + B)
Chair: Wisit Supakarapongkul (THA)             Co-chair: Tay Eng Hseon (SIN)

11.00 -11.10

Strategies for comprehensive cervical cancer control in Asia

Neerja Bhatla (IND)

11.10 - 11.20

Current cervical cancer control in Korea

Jae-Kwan Lee (KOR)

11.20 - 11.30

Cost-effectiveness of  cervical cancer control

Wichai Termrungruanglert (THA)

11.30 - 11.40

Strategies towards elimination of cervical cancer in Australia

Suzanne Garland (AUS)

11.40 - 11.50

Combined strategies of HPV vaccination & screening  in Philippines

Efren Domingo (PHI)

11.50 - 12.00

Discussion

 

   12.00-13.00 Sponsored Symposium 3 (MSD (Thailand), Ltd.): Advancing the Treatment of Cervical and Endometrial Cancers with Immunotherapy
                              Speakers: Robert Coleman (USA) , Apichai Vasuratna (THA)              

13.00-14.30 (Special Symposium 5) Major clinical research advances in gynecologic cancer in 2021
                              Chair: Jae-Weon Kim (KOR)      Co-chair: Xiao-Hua Wu (CHN)

13.00-13.20

Cervical cancer

Tingyan Shi (CHN)

13.20-13.40

Uterine cancer

Yoo-Young Lee (KOR)

13.40-14.00

Ovarian cancer

Jonathan Ledermann (GBR)

14.00-14.20

Other gynecologic cancers (vulvar cancer, sarcoma)

Kosei Hasegawa (JPN)

14.20-14.30

                          Discussion

 

14.30-15.00  Break

15.00-16.00 (Tumor Board 2) Treatment for neuroendocrine carcinoma of the cervix & salvage therapy for endometrial cancer
                               
Chair:  Hidemichi Watari (JPN)      Co-chair:  Jianliu Wang (CHN)

15.00-15.10

Case presentation 1: Treatment for neuroendocrine
carcinoma of the cervix

Natacha Phoolcharoen (THA)

15.10-15.25

Comments on case management

Yusuke Kobayashi (JPN)

15.25-15.30

Discussion

 

15.30-15.40

Case presentation 2: Salvage therapy for endometrial cancer

Gang Chen (CHN)

15.40-15.55

Comments on case management

Xiaojun Chen (CHN)

15.55-16.00

Discussion

 

16.00-17.20 (Special Session 6) JGO Session: Research planning and methodology
Chair: Yawana Tanapat (THA)                  Co-chair: Dong-Hoon Suh (KOR)

16.00-16.20

Misconduct in medical writing

Seung-Hyuk Shim (KOR)

16.20-16.40

How to be a big paper author?

Duk-Woo Park (KOR)

16.40-17.00

Research using ‘cancer registration data’

Cheng-I Liao (TWN)

17.00-17.20

Discussion

 

 

Room B Day2- November 26, 2021 (Friday)

Time

Program

Speaker/Country/Region

8.30-10.30 (Special Session 4) AOFOG-ASGO session: joint committee symposium of oncology
                                                      and minimally invasive gynecologic surgery
                                   Title: Challenges for minimally invasive treatment on gynecologic cancers: What did we learn from global reports and what should we stand for?
Chair: Sarikapan Wilailak (THA)                         Co-chair: Tsukasa Baba (JPN)

8.30-8.40

Opening Remarks

Kazunori Ochiai, JPN, President of AOFOG
Daisuke Aoki, Japan, President of ASGO

8.40- 8.50

Basic concept in the surgical treatment of gynecologic cancers

Kimio Ushijima (Kurume U.,JPN)

8.50-9.00

Current Asian trend in minimally invasive surgery

Jeong-Yeol Park (KOR)

9.00-9.25

Current status and future perspective of MIS in US

Mario Leitao (USA)

9.25-9.35

Training of MIS from box to cadaver

Amphan Chalermchokecharoenkit (Mahidol U., THA)

9.35-10.00

Robotic surgery and training for gynecologic cancers

Henrik Falconer (Karolinska U., SWE)

10.00-10.15

Discussion and comments

All speakers

10.15-10.25

Q & A

 

10.25-10.30

Closing remark

Pisake Lumbiganon (THA) President Elect of AOFOG

10.30-11.00  Break

12.00-13.00  Sponsored Symposium 4 (AstraZeneca (Thailand), Ltd.): Dare to Challenge a Paradigm Shift in Advanced Ovarian Cancer Treatment
Speaker: Basel Refky (EGY): Ovarian cancer and genetic testing in precision medicine era: What do clinicians need to know
Speaker: Jonathan Ledermann (GBR): Selecting ovarian cancer patients by biomarker status to the right treatment
Moderator: Wichai Termrungruanglert (THA)

13.00-14.30 Oral presentation: Cervix/Vulva
                                        Chair: Toshiharu Kamura (JPN)     Co-chair: Navamol Lekskul (THA)

13.00-13.10

Treatment experience of neuroendocrine carcinoma of the cervix in hospitals in three cities: Tokyo-Seoul-Beijing

Yusuke Kobayashi (JPN)

13.10-13.20

 

Speaker 2

13.20-13.30

 

Speaker 3

13.30-13.40

 

Speaker 4

13.40-13.50

 

Speaker 5

13.50-14.00

 

Speaker 6

14.00-14.10

 

Speaker 7

14.10-14.20

 

Speaker 8

14.20-14.30

 

Speaker 9

14.30-15.00 Break

15.00-16.30  Oral presentation Ovary/Uterus (additional rooms can be added)
Chair:  Andri Andrijono (INA)        Co-chair: Apichai Vasuratna (THA)

15.00-15.10

 

Speaker 1

15.10-15.20

 

Speaker 2

15.20-15.30

 

Speaker 3

15.30-15.40

 

Speaker 4

15.40-15.50

 

Speaker 5

15.00-16.00

 

Speaker 6

16.00-16.10

 

Speaker 7

16.10-16.20

 

Speaker 8

16.20-16.30

 

Speaker 9

 

Room C Day2- November 26, 2021 (Friday)

Time

Program

Speaker/Country/Region

   11.00-12.00 Sponsored Symposium 5 (GlaxoSmithKline Pte Ltd.): Treatment for ovarian and endometrial cancers: the management of ovarian and endometrial cancer: current landscape and future perspective
Chair: Sarikapan Wililak (THA)
Speakers: Bradley Monk (USA) and David SP Tan (SIN)
13.00-14.30             Oral presentation: Chair:                                                      Co-chair:
13.00-13.10   Speaker1
13.10-13.20   Speaker2
13.20-13.30   Speaker3
13.30-13.40   Speaker4
13.40-13.50   Speaker5
13.50-14.00   Speaker6
14.00-14.10   Speaker7
14.10-14.20   Speaker8
14.20-14.30   Speaker9
     
14.30-15.00 Break
15.00-16.30             Oral presentation                                        
Chair:                                                                   Co-chair:
15.00-15.10   Speaker1
15.10-15.20   Speaker2
15.20-15.30   Speaker3
15.30-15.40   Speaker4
15.40-15.50   Speaker5
15.50-16.00   Speaker6
16.00-16.10   Speaker7
16.10-16.20   Speaker8
16.20-16.30   Speaker9
     
 
 

 

 

 

November 27, 2021

 

Room A Day3- November 27, 2021 (Saturday)

Time

Program

Speaker/Country/Region

8.30-9.30 (Special Session 7) ASGO-IGCS Joint session:  Frontline surgery and education in ovarian cancer (Room A + B)
Chair: Rongyu Zang (CHN)        Co-chair: Keiichi Fujiwara (JPN)

8.30-8.45

Timing of frontline surgery, including the role of HIPEC

Boonlert Viriyapak (THA)

8.45-9.00

Assessing surgical quality & educational activity in Asia

Suk-Joon Chang (KOR)

9.00-9.15

IGCS surgical film festival and surgeryU

Ane Gerda Eriksson (NOR)

9.15-9.30

Discussion

 

9.30-10.30 (Symposium 4)  MIS for early-stage cervical cancer: A final or a continuum
Chair: Duk-Soo Bae (KOR)          Co-chair: Chailert Phong-Narisorn (THA)

9.30-9.45

MIS for early-stage cervical cancer: A final

Pedro Ramirez (USA)

9.45-10.00

MIS for early-stage cervical cancer: A continuum

Hiroyuki Kanao (JPN)

10.00-10.15

Minimally invasive surgery for cervical cancer: data analysis based on Chinese's multi-center and technology improvement

Zhiqing Liang (CHN)

10.15-10.30

Discussion

 

10.30-11.00 Break

11.00-12.00 Surgical films in gynecologic cancer
Chair: Masaki Mandai (JPN) Co-chair: Chuenkamon Charakorn (THA)

11.00 -11.10

 

 

11.10 – 11.20

 

 

11.20 – 11.30

 

 

11.30 – 11.40    
11.40 – 11.50    

11.50 – 12.00

 

 

12.00-12.30           Closing Ceremony
                                - Address by next ASGO President
                                - Presentation of Best Abstract Awards & Young Gynecologic Oncologist Awards 
                                - PR for the next ASGO 2022 workshop meeting in Beijing                                                  


                                                    




Room B Day3- November 27, 2021 (Saturday)

Time

Program

Speaker/Country/Region

9.30-10.30 Sponsored Symposium 6 (Becton Dickinson Holdings Pte. Ltd.): Leveraging the old and new in cervical cancer
 screening: Learnings and implementations
Speaker: Aisha Dhewar (SIN)

10.30-11.00   Break

11.00-12.00 (Education Session 2): How to optimize treatment outcomes for locally advanced cervical cancer 
Chair:  Ji-Hong Liu (CHN)                 Co-chair: Taek-Sang Lee (KOR)

11.00 -11.15

Surgical vs. clinical staging prior to chemoradiation therapy (CRT)

Tze-Chien Chen (TWN)

11.15 – 11.30

Neoadjuvant chemotherapy vs. CRT with/without adjuvant Rx

Sudeep Gupta (IND)

11.30 – 11.45

Improving CRT outcomes with current radiation technique

Hyun-Cheol Kang (KOR)

11.45 – 12.00

Improving CRT outcomes with current chemotherapy/ targeted
therapy

Hui Wang (CHN)

12.00-12.30                                  Closing Ceremony
                                 - Address by next ASGO President
                                 - Presentation of Best Abstract Awards & Young Gynecologic Oncologist Awards 
                                 - PR for the next ASGO 2022 workshop meeting in Beijing                                                  

 

 

Contact Us

Bangkok, Thailand

asgo2021@gmail.com

+66835436890

Your message has been sent. Thank you!